How is Creutzfeldt-Jakob disease acquired?

Neuroepidemiology

Volumn 19, Issue 2, 2000, Pages 55-61

  Alter, Milton ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Cannibalism; Creutzfeldt Jakob disease; Latrogenic transmission; Prions; PRNP mutation; Spongiform encephalopathy

Indexed keywords

GONADOTROPIN; HUMAN GROWTH HORMONE; PRION PROTEIN;

BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN TISSUE; CADAVER; CANNIBALISM; CONTAMINATION; CORNEA TRANSPLANTATION; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; EATING; GENE MUTATION; HOMOZYGOSITY; HYPOPHYSIS; IATROGENIC DISEASE; INFECTION; INSTRUMENT; POSTOPERATIVE COMPLICATION; PRION DISEASE; REVIEW; SUTURE;

EID: 0033994057     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026239     Document Type: Review

References (28)

1. Creutzfeldt HG: Üher eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Gesamte Neurol Psychiatric 1920;57:1-18.
2. Bruton CJ, Bruton RK, Gentleman SM, Roberts GW: Diagnosis and incidence of prion (Creutzfeldt-Jakob) disease: A retrospective archival survey with implications for future research. Neurodegeneration 1995; 4:357-368.
3. Kahana E, Alter M, Braham J, Sofer D: Creutzfeldt-Jacob disease. Focus among Libyan Jews in Israel. Science 1974;183:90-91.
4. Cathala F,. Brown P, Le Canuet P, Gajdusek DC: High incidence of Creutfeldt-Jakob disease in North African immigrants to France. Neurology 1985;35:894-895.
5. Araya G. Gálvez S. Carter L. Gajdusek DC: A spatiotemporal clustering of Creutzfeldt-Jakob disease in Chile. Rev Chil Neuropsiquiatr 1983;21:291-295.
6. Mayor V, Orolin D, Mitrová E: Cluster of Creutzfeld-Jakob disease and presenile dementia. Lancet 1997;ii:256.
7. Prusiner SB, Hsiaj KH: Human prion diseases. Ann Neurol 1994;35: 385-395.
8. Brown P: Environmental causes of human spongiform encephalopathy; in Baker HF, Ridley RM (eds): Methods in Molecular Medicine: Prion diseases. Totowa, Humana Press, 1996, pp 139-154.
9. Gajdusek DC, Zigas V: Degenerative disease of the central nervous system in New Guinea: The endemic occurrence of 'kuru' in the native population. N Engl J Med 1957;257:974-981.
10. Hadlow WJ: Scrapie and kuru, Lancet 1959;ii:289-290.
11. Klatzo I, Gajdusek CD, Zigas V: Pathology of kuru. Lab Invest 1959;8: 799-847.
12. Duffy P, Wolf J, Collins G, DeVoe AG, Streeton B, Cowen D: Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692-693.
13. Heckmann JG, Lang CJG, Petruch F, Druschky A, Erb C, Brown P, Neundörfer B: Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J Neurol Neurosurg Psychiatry 1997;63:388-390.
14. Hogan RN, Cavanaugh HD: Transplantation of corneal tissue from donors with diseases of the central nervous system. Cornea 1995;14:547-553.
15. Davanipour Z, Alter M, Sobel E, Asher DM: Dementia: Possible transmission by trauma, surgery, sutures and tonometers. Neurology 1985;35:241.
16. Koch TK, Berg BO, DeArmond SJ, Gravina RF: Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. N Engl J Med 1985;313:731-733.
17. Pocehiari M, Peano S,. Conz A, Eshkol A, Maillard F, Brown P, Gibbs CJ, Xi YG, Tenham-Fisher E, Macchi G: Combination ultrafiltration and 6 M urea treatment of human growth hormone effectively minimizes risk from potential Creutzfeldt-Jakob disease virus contamination. Horm Res 1991;35:161-166.
18. Cochins JI, Burns RJ, Blumbergs PC, Mack K, Alderman DP: Creutzfeldt-Jakob in a recipient of human pituitary derived gonadutrophin. Aust NZ J Med 1991;20:592-593.
19. Thadani V, Penar PL, Partington J, Kalb R, Janssen R, Schonberger LB, Rabkin CS, Prichard JW: Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg 1988;69:766-769.
20. Tange RA, Troost D, Limburg M: Progressive fatal dementia (Creutzfeldt-Jakob disease) in a patient who received homograft tissue for tympanic membrane closure. Eur Arch Otorhinolaryngol 190;247:199-201.
21. Esmonde TFG, Will RG, Slattery JM, Knight R, Harries-Jones R, de-Silva R, Matthews WB: Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993;341:205-207.
22. Heye N, Hensen S, Müller N: Creutzfeldt-Jakob disease and blood transfusion. Lancet 1994;343:298.
23. Wilesmith JW: Bovine spongiform encephalopathy: Methods of analyzing the epidemic in the United Kingdom: in Baker HF, Ridley RM (eds): Methods in Molecular Medicine: Prion Diseases. Totowa Human Press, 1996, pp 155-173.
24. Bons N, Mestre-Frances N, Belli P, Cathala F, Gajdusek DC, Brown P: Natural and experimental oral infection of non-human primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci USA 1999;96:4046-4051.
25. Weintjens DPWM, Will RG, Hofman A: Creutzfeldt-Jakob disease: A collaborative study in Europe. J Neurol Neurosurg Psychiatry 1994; 57:1285-1299.
26. Collinge J, Sidle KCL, Heads J, Ironside JW, Hill AF: Molecular analysis of prion strain variation and the actiology of 'new variant' CJD. Nature 1996;383:685-690.
27. Will RG, Ironside JW, Zeidler M, Estibiero K, Alperovitch A, Poser S, Pocchari M, Hofman A, Smith PG: A new variant of Creutzfeldt-Jakob disease in the UK: Lancet 1996;347: 921-925.
28. Consens SN, Linsell L, Smith PG, Chandrakumar M, Wilesmith JW, Knight RSG, Zeidler M, Stewart G, Will RG: Geographical distribution of variant CJD in the UK (excluding Northern Ireland). Lancet 1999; 353:18-21.